Strongyloides stercoralis (threadworm)

Strongyloides stercoralis, commonly known as the threadworm, is a small parasitic nematode capable of infecting cats, humans, and various other mammals. This parasite has a unique life cycle that allows it to complete its development either within a host or in the external environment, contributing to its persistence in endemic areas. While cats are not the primary natural host for Strongyloides stercoralis, they can become infected and develop clinical disease, particularly when exposed to contaminated environments or when immune function is compromised. The zoonotic nature of this parasite, meaning it can transmit between animals and humans, makes it particularly significant from a public health perspective.

Infection occurs primarily when infective larvae penetrate the skin or are ingested from contaminated environments. The parasite thrives in warm, humid conditions where larvae can survive and develop in soil contaminated with feces from infected hosts. Cats living in tropical and subtropical regions, those housed in unsanitary conditions, or those with access to contaminated outdoor areas face the highest risk of exposure. Once larvae enter the body, they undergo migration through tissues before establishing in the small intestine where adult females reproduce and release larvae that are passed in feces. A concerning feature of this parasite is its capacity for autoinfection, where larvae develop to the infective stage within the host and reinfect without leaving the body.

The impact of Strongyloides stercoralis infection varies dramatically depending on the cat's immune status and the intensity of infection. Immunocompetent cats may harbor low-level infections with minimal clinical signs, while immunocompromised individuals can develop overwhelming parasitism through the autoinfection cycle. In severe cases, known as disseminated strongyloidiasis or hyperinfection syndrome, massive numbers of larvae migrate through tissues causing potentially fatal multi-organ damage. The respiratory and gastrointestinal systems bear the brunt of clinical disease, with affected cats showing combinations of diarrhea, weight loss, coughing, and respiratory distress.

Treatment of Strongyloides stercoralis infection is possible with appropriate antiparasitic medications, though the parasite's autoinfection capability can make elimination challenging, particularly in immunocompromised hosts. Early recognition and treatment before the infection becomes established improves outcomes significantly. The zoonotic potential of this parasite means that infected cats can pose risks to human family members, especially immunocompromised individuals, making diagnosis and treatment important not only for feline health but for household safety. Cat owners in endemic areas should be aware of this parasite and work with their veterinarians to maintain appropriate hygiene and screening protocols.

The primary cause of Strongyloides stercoralis infection in cats is exposure to infective third-stage larvae present in contaminated environments. These larvae develop from eggs or larvae passed in the feces of infected hosts, undergoing free-living development in soil under appropriate environmental conditions. Warm temperatures and high humidity favor larval survival and development, explaining the parasite's concentration in tropical and subtropical regions. When cats contact contaminated soil, bedding, or other surfaces, infective larvae actively penetrate the skin, typically through the feet or belly, initiating infection. Oral ingestion of larvae from grooming contaminated fur or consuming contaminated food or water provides an alternative infection route.

The complex life cycle of Strongyloides stercoralis contributes to its persistence and pathogenic potential. Larvae entering through the skin migrate through tissues, typically traveling via the bloodstream to the lungs where they penetrate into airways, are coughed up and swallowed, ultimately reaching the small intestine. In the intestine, larvae develop into adult females that reproduce parthenogenetically, producing eggs and larvae without mating. Larvae are passed in feces and can either develop in the environment through free-living generations or develop directly into infective larvae capable of immediately reinfecting the same host or new hosts.

Autoinfection represents a particularly concerning feature of Strongyloides stercoralis biology. Some larvae passed in the intestine can develop to the infective stage before leaving the host's body, then penetrate the intestinal wall or perianal skin to reestablish infection without any environmental exposure. This internal amplification cycle can lead to progressively increasing worm burdens over time. In immunocompromised hosts unable to control parasite reproduction, autoinfection can spiral into hyperinfection syndrome with overwhelming parasitism and dissemination of larvae throughout body tissues.

Risk factors for Strongyloides stercoralis infection include geographic location in endemic tropical or subtropical areas, housing conditions with poor sanitation and fecal contamination, outdoor access in warm humid environments, and any condition compromising immune function. Cats receiving immunosuppressive medications such as corticosteroids face particularly high risk of developing severe infection if exposed. Concurrent illness affecting immune competence similarly predisposes to serious disease. Cats in crowded colony situations or shelters in endemic areas may face repeated exposure and reinfection.

The pathogenic mechanism of Strongyloides stercoralis involves multiple phases of tissue damage. Initial skin penetration causes local irritation and inflammation. Larval migration through the lungs creates small hemorrhages and inflammatory foci that can coalesce into pneumonia with heavy infections. Adult worms in the intestine damage the mucosal lining, causing inflammation, malabsorption, and diarrhea. In hyperinfection syndrome, massive larval migration damages multiple organs, and larvae may carry intestinal bacteria into normally sterile tissues, causing secondary bacterial infections including potentially fatal sepsis.

Early warning signs of Strongyloides stercoralis infection in cats are often subtle and may be overlooked entirely in immunocompetent individuals with low-level infections. Mild, intermittent diarrhea may be the first indication of intestinal infection. Slight skin irritation, particularly on the feet or belly where larvae have penetrated, might be noticed as increased grooming or mild dermatitis. Occasional coughing during the larval migration phase through the lungs may occur but is easily attributed to other causes. These early signs frequently go unrecognized, allowing infection to become established before diagnosis is pursued.

Common symptoms of established Strongyloides stercoralis infection reflect involvement of the gastrointestinal and respiratory systems. Chronic or recurrent diarrhea is the most frequently observed sign, varying from soft stools to profuse watery diarrhea in more severe cases. Weight loss develops as intestinal damage impairs nutrient absorption. Intermittent vomiting may occur. Respiratory signs including coughing, increased respiratory rate, and labored breathing reflect pulmonary involvement from larval migration. Poor coat condition and general unthriftiness develop as the overall health impact accumulates.

Behavioral changes in cats with Strongyloides stercoralis infection often reflect discomfort and malaise. Decreased activity and increased time spent resting indicate the cat is not feeling well. Appetite may decrease despite weight loss. Some cats show abdominal discomfort, evidenced by reluctance to be handled or unusual postures. Grooming behavior may be altered, with some cats grooming excessively, particularly around the feet and belly where skin irritation occurs, while others groom less as they feel generally unwell. Withdrawal from social interactions and decreased interest in play or exploration commonly occur.

Physical signs observable during examination include poor body condition with muscle wasting and prominent bones. The coat often appears dull, dry, and unkempt. Skin lesions may be visible on the feet, belly, or other areas of larval penetration, appearing as reddened, irritated patches or papules. Dehydration develops in cats with significant diarrhea, manifested as decreased skin elasticity and tacky gums. Auscultation of the lungs may reveal increased respiratory sounds in cats with pulmonary involvement. Abdominal palpation may elicit discomfort or reveal thickened intestinal loops.

Symptom progression in untreated Strongyloides stercoralis infection varies dramatically based on the host's immune status. In immunocompetent cats, infection may remain relatively stable or even self-limit to some degree. However, in immunocompromised hosts, the autoinfection cycle leads to progressively worsening disease. Diarrhea becomes more severe and intractable. Respiratory signs worsen as increasing numbers of larvae migrate through the lungs. Weight loss accelerates to the point of cachexia. The cat becomes progressively more debilitated and may develop secondary infections as immune defenses fail.

Emergency symptoms requiring immediate veterinary attention include signs of hyperinfection syndrome or disseminated strongyloidiasis. Severe respiratory distress with open-mouth breathing, cyanosis, or complete inability to breathe comfortably indicates life-threatening pulmonary involvement. Profuse, uncontrollable diarrhea leading to severe dehydration and shock requires emergency intervention. Signs of sepsis including high fever, extreme weakness, collapse, and altered mentation suggest bacterial dissemination accompanying larval migration. Any immunocompromised cat showing worsening symptoms despite treatment needs urgent reassessment. These severe manifestations can be rapidly fatal without aggressive intervention.

Initial veterinary examination of cats with suspected Strongyloides stercoralis infection involves detailed history and thorough physical assessment. The veterinarian will ask about the cat's living environment, geographic location, outdoor access, and any immunosuppressive conditions or medications. Signs of skin irritation, particularly on the feet and ventral surfaces, will be noted. Respiratory examination assesses breathing rate, effort, and lung sounds. Abdominal palpation evaluates intestinal thickening and discomfort. Body condition scoring documents the nutritional impact of infection. This comprehensive assessment guides selection of appropriate diagnostic tests.

Fecal examination is the primary diagnostic method for confirming Strongyloides stercoralis infection. However, this parasite presents diagnostic challenges because larvae rather than eggs are typically found in feces, requiring different techniques than those used for most other intestinal parasites. The Baermann technique, which uses the larvae's attraction to warmth and moisture to concentrate them, provides the most sensitive detection method. Fresh feces must be examined promptly because larvae deteriorate rapidly and may be missed in old samples. Multiple samples may be needed because larval shedding can be intermittent, particularly in light infections. Direct smears of fresh feces can detect larvae in moderate to heavy infections.

Additional diagnostic testing may be warranted based on clinical presentation. Complete blood count often reveals eosinophilia, an increase in eosinophil white blood cells commonly associated with parasitic infections, though this finding is nonspecific. Chest radiographs may show diffuse interstitial or alveolar patterns in cats with significant pulmonary involvement. Transtracheal wash or bronchoalveolar lavage can identify migrating larvae in the respiratory tract. Intestinal biopsy may reveal adult worms in the mucosa along with characteristic inflammatory changes. Serological testing is available in some regions but is not widely used in veterinary practice. In hyperinfection cases, larvae may be found in sputum, body fluids, or tissues outside the gastrointestinal tract.

Differential diagnosis for the varied clinical signs of strongyloidiasis includes numerous conditions. Other intestinal parasites cause chronic diarrhea and weight loss. Inflammatory bowel disease produces similar gastrointestinal symptoms and requires differentiation through biopsy. Infectious causes of respiratory disease including viral, bacterial, and other parasitic infections must be considered in cats with pulmonary signs. In immunocompromised cats, opportunistic infections may mimic or complicate strongyloidiasis. Accurate diagnosis is particularly important given the zoonotic potential of Strongyloides stercoralis and the specific treatment required for elimination. The possibility of this infection should be considered in cats from endemic areas presenting with compatible clinical signs, especially those receiving immunosuppressive therapy.

Initial treatment of cats with Strongyloides stercoralis infection addresses stabilization and supportive care alongside antiparasitic therapy. Cats with significant dehydration require fluid therapy to restore hydration and electrolyte balance before or concurrent with deworming. Nutritional support through easily digestible, high-calorie foods addresses malnutrition while avoiding overtaxing the compromised intestinal tract. Cats with respiratory distress may need oxygen supplementation and careful monitoring. In cases of suspected secondary bacterial infection or sepsis, appropriate antibiotic therapy is essential. The overall condition of the cat must be stabilized to allow safe administration of antiparasitic medications.

Medical management focuses on antiparasitic medications capable of eliminating Strongyloides stercoralis from the host. Ivermectin is the treatment of choice, demonstrating excellent efficacy against this parasite when administered at appropriate doses. Treatment typically requires multiple doses over days to weeks to address all life stages including any autoinfection cycles. Fenbendazole represents an alternative that can be used when ivermectin is contraindicated. Thiabendazole has historical use but is less commonly available. The unique autoinfection capability of Strongyloides stercoralis means that treatment protocols may need to be more aggressive and prolonged than for other intestinal parasites to achieve complete elimination.

Management of immunocompromised patients with Strongyloides stercoralis infection presents particular challenges. The autoinfection cycle can perpetuate despite treatment if immune suppression continues. Reducing or discontinuing immunosuppressive medications when possible helps the cat's own immune system contribute to parasite control. However, this must be balanced against the underlying condition requiring immunosuppression. Extended or repeated courses of antiparasitic therapy may be necessary. Close monitoring for signs of treatment failure or relapse is essential. In some cases, lifelong suppressive therapy may be needed to prevent recrudescence.

Supportive care during treatment addresses the multiple organ systems potentially affected by strongyloidiasis. Gastrointestinal support includes dietary management, anti-diarrheal medications if appropriate, and probiotics to support intestinal recovery. Respiratory support ranges from simple monitoring to oxygen supplementation in severely affected cats. Pain management may be needed for cats with significant abdominal discomfort. Skin lesions at larval penetration sites typically resolve with elimination of the parasite but may require symptomatic treatment in the interim. Broad-spectrum antibiotics address secondary bacterial infections, particularly important in hyperinfection cases.

Complementary approaches can support recovery alongside conventional treatment. Nutritional supplements including omega-3 fatty acids and antioxidants may support tissue healing. Probiotics help restore healthy intestinal flora following parasitic and antibiotic insults. Immune support through appropriate nutrition and stress reduction benefits overall recovery. However, no alternative therapies have proven efficacy against Strongyloides stercoralis itself, and conventional antiparasitic treatment remains essential for elimination.

Treatment decisions must consider the cat's immune status, severity of infection, zoonotic risks to household members, and likelihood of reexposure. The zoonotic potential of Strongyloides stercoralis creates urgency for treatment to protect human family members, particularly any who are immunocompromised. Environmental decontamination reduces reinfection risk but is challenging given the parasite's ability to survive in appropriate environments. Treatment success can be monitored through repeat fecal examinations looking for larval clearance, though follow-up testing should continue for an extended period given the autoinfection potential. In immunocompromised patients or those in heavily contaminated environments, ongoing monitoring and possibly suppressive treatment may be needed indefinitely.

Recovery from Strongyloides stercoralis infection follows a variable timeline depending on the severity of infection and the host's immune status. Cats with uncomplicated infections typically show clinical improvement within one to two weeks of starting effective treatment. Diarrhea resolves as intestinal damage heals, and appetite and energy levels improve. Respiratory signs, if present, diminish as pulmonary inflammation subsides. Weight gain becomes apparent over the following weeks as nutritional status is restored. Complete recovery in immunocompetent cats with mild to moderate infection usually occurs within four to eight weeks.

Post-treatment care requirements focus on confirming parasite elimination and preventing reinfection. Repeat fecal examinations using the Baermann technique should be performed periodically for several months after treatment to verify clearance, as the autoinfection potential of this parasite means that incomplete treatment can lead to recrudescence. Continued attention to nutritional rehabilitation supports complete recovery. Environmental management including cleaning and decontaminating areas used by the infected cat reduces reinfection risk. Monitoring for any return of clinical signs allows early intervention if relapse occurs.

Prognosis for cats treated for Strongyloides stercoralis infection varies significantly based on disease severity and host factors. Immunocompetent cats with mild to moderate infection generally have excellent prognoses with appropriate treatment, achieving complete cure and return to normal health. More heavily infected cats may require longer recovery periods and could have some residual effects from intestinal damage. Immunocompromised cats face guarded to poor prognoses, particularly those with hyperinfection syndrome or disseminated disease. The ability to reduce or eliminate immunosuppression significantly impacts outcome in these patients.

Long-term outlook for cats surviving Strongyloides stercoralis infection depends largely on ability to prevent reinfection and maintain adequate immune function. Cats in endemic areas with continued environmental exposure face ongoing reinfection risk. Those receiving long-term immunosuppressive therapy may require periodic screening and possibly prophylactic treatment. Cats that recover fully and avoid reexposure can expect normal lifespan and quality of life. The zoonotic implications of this parasite make follow-up confirmation of cure particularly important for protecting human household members.

Primary prevention of Strongyloides stercoralis infection focuses on minimizing exposure to contaminated environments and maintaining conditions that limit parasite survival. Environmental sanitation is paramount, with prompt removal and proper disposal of feces preventing buildup of infective larvae. Keeping cats housed in clean, dry areas discourages the warm, moist conditions that favor larval survival. Limiting outdoor access in endemic areas reduces exposure to contaminated soil. Regular cleaning and disinfection of housing areas, particularly in shelters, catteries, and multi-cat environments, reduces environmental contamination levels.

Environmental management strategies address the specific conditions that support Strongyloides stercoralis survival. Improving drainage to reduce soil moisture decreases larval survival in outdoor areas. Removing organic debris that retains moisture similarly creates less favorable conditions. Concrete or gravel surfaces rather than bare soil reduce environmental contamination in runs and exercise areas. Indoor housing in climate-controlled environments essentially eliminates exposure for cats in endemic regions. However, complete environmental decontamination is extremely difficult once an area becomes heavily contaminated.

Dietary considerations for Strongyloides stercoralis prevention are minimal since transmission occurs through skin penetration or ingestion of larvae rather than through food. Maintaining cats on nutritionally complete diets supports immune function, which helps control any infections that do occur. Ensuring food and water are not contaminated with feces or soil prevents one potential ingestion route. There are no specific dietary supplements proven to prevent Strongyloides stercoralis infection.

Routine veterinary care provides opportunities for screening and early detection of Strongyloides stercoralis infection. Periodic fecal examinations using appropriate techniques for larval detection should be considered for cats in endemic areas or those with risk factors. Cats about to receive immunosuppressive therapy should ideally be screened for this parasite given the risk of hyperinfection in immunocompromised hosts. Pre-adoption screening of cats from endemic regions or high-risk backgrounds protects new households from introduction of this zoonotic parasite. Annual wellness examinations allow discussion of risk factors and appropriate prevention strategies.

Early intervention when Strongyloides stercoralis infection is suspected limits both disease severity and zoonotic transmission risk. Prompt treatment of infected cats reduces environmental contamination and protects human household members. Screening and treating all cats in multi-cat environments simultaneously prevents ongoing transmission within the group. Identifying and treating infection before administering immunosuppressive therapy prevents the development of hyperinfection syndrome. Cat owners in endemic areas should maintain awareness of this parasite and seek veterinary attention promptly when suggestive signs occur.

Daily management of cats being treated for Strongyloides stercoralis infection requires attention to medication administration, hygiene, and monitoring. Antiparasitic medications must be given exactly as prescribed, with the full course completed even as clinical signs resolve. The potential for autoinfection makes treatment compliance particularly important. Litter boxes should be cleaned at least daily, and feces disposed of properly to prevent environmental contamination and reduce autoinfection risk through larval contact. Hand washing after handling the cat or cleaning litter boxes protects human household members from zoonotic transmission. Immunocompromised family members should minimize direct contact until treatment is confirmed successful.

Home environment modifications support treatment success and prevent transmission. Keeping the infected cat's living area clean and dry discourages larval survival. Washable bedding should be laundered regularly in hot water. Hard surfaces can be cleaned with appropriate disinfectants. Limiting the cat's access to other areas of the home during treatment reduces potential contamination. Outdoor access should be restricted to prevent environmental contamination and reduce exposure to additional infective larvae. In multi-cat households, isolating infected individuals until treatment is complete prevents transmission to housemates.

Maintaining quality of life during treatment and recovery involves balancing infection control measures with normal feline needs. Cats should have comfortable, clean resting areas and access to enrichment activities appropriate to their energy level during recovery. Nutritious food and fresh water support healing. Social interaction with family members can continue with appropriate hygiene precautions. As cats improve, normal activities including play and exploration can gradually resume. The goal is recovery with minimal disruption to the human-animal bond.

Ongoing monitoring ensures treatment success and detects any relapse. Clinical signs including stool quality, respiratory status, and body condition should be tracked throughout treatment and recovery. Follow-up fecal examinations at prescribed intervals confirm parasite elimination. Weight should be monitored to ensure nutritional recovery. Any recurrence of symptoms warrants prompt veterinary attention given the autoinfection potential of this parasite. For immunocompromised cats or those in endemic areas, extended or ongoing monitoring may be recommended.

Caregiver support for owners managing Strongyloides stercoralis infection includes education about the zoonotic nature of this parasite and appropriate precautions. Understanding the importance of complete treatment and follow-up helps ensure compliance. Managing concerns about human health risks requires honest communication about actual transmission risks and protective measures. Treatment costs vary based on disease severity and duration of therapy needed. Veterinary staff can provide guidance on environmental management and hygiene practices tailored to the household situation.

Strongyloides stercoralis infection does not demonstrate breed predisposition, as susceptibility relates entirely to environmental exposure and host immune status rather than genetic factors. Any cat exposed to contaminated environments in endemic areas can become infected regardless of breed. The parasite has no preference for particular cat breeds, sizes, or coat types. Risk is determined by geography, living conditions, and immune competence rather than ancestry or pedigree. Prevention and treatment recommendations apply universally across all cat breeds and mixed-breed cats.

Lifestyle and geographic factors are the primary determinants of Strongyloides stercoralis infection risk. Cats living in tropical and subtropical regions where warm, moist conditions favor larval survival face the highest exposure risk. Outdoor cats in these areas encounter contaminated soil during normal activities. Cats in shelters, catteries, or colony situations in endemic areas may experience ongoing exposure and reinfection. Indoor-only cats in climate-controlled environments face minimal risk regardless of geographic location. Immunocompromised cats of any breed receiving steroids or other immunosuppressive medications are at particular risk of developing severe disease if infected.

Screening recommendations focus on risk-based assessment rather than breed-specific protocols. Cats in endemic geographic areas should be considered for periodic fecal screening using appropriate techniques for larval detection. Any cat about to begin immunosuppressive therapy should be screened to identify and treat infection before immune suppression increases disease severity. Newly acquired cats from high-risk regions or backgrounds warrant evaluation. Cats showing compatible clinical signs of chronic diarrhea and respiratory involvement should be tested regardless of breed. The emphasis is on identifying individual risk factors rather than targeting particular breeds.

Several conditions commonly co-occur with or result from Strongyloides stercoralis infection. Secondary bacterial infections develop when migrating larvae carry intestinal bacteria into normally sterile tissues, potentially causing pneumonia, septicemia, or localized infections. Malnutrition and malabsorption result from intestinal damage, leading to deficiencies in protein, vitamins, and minerals. Anemia may develop from a combination of intestinal blood loss and nutritional deficiency. In cats receiving immunosuppressive therapy, the underlying condition requiring treatment coexists with and may be exacerbated by parasitic infection.

Conditions producing similar symptoms to Strongyloides stercoralis infection require differentiation for appropriate treatment. Other intestinal parasites including hookworms and other nematodes cause chronic diarrhea and weight loss. Inflammatory bowel disease presents with similar gastrointestinal signs. Respiratory parasites such as lungworms cause coughing and breathing difficulties. Systemic infections affecting multiple organ systems may mimic disseminated strongyloidiasis. In immunocompromised hosts, opportunistic infections of various types can present similarly. Accurate diagnosis requires appropriate testing specifically for Strongyloides larvae.

Potential complications of untreated or inadequately treated Strongyloides stercoralis infection can be severe, particularly in immunocompromised hosts. Hyperinfection syndrome develops when uncontrolled autoinfection leads to overwhelming parasitism with larvae migrating throughout body tissues. Disseminated strongyloidiasis involves larval spread to organs not normally in the parasite's migration pathway. Gram-negative sepsis can occur when larvae transport intestinal bacteria into the bloodstream. Respiratory failure from severe pulmonary involvement may develop. Multi-organ failure in disseminated disease carries a grave prognosis. These severe complications underscore the importance of early diagnosis and complete treatment, particularly in immunocompromised patients.